Indeed, when tumour accrual for the entire group ( n = 32) is assessed, irrespective of drug regimen, the median number of FOXP3 + T cells were higher in KTRs who developed SCC but did not reach statistical significance (data not shown).
← all excerpts
Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
1
—
—